drugset / Trial / NCT00348972
Lantus in Prediabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the safety, tolerability, and efficacy of Lantus® (insulin glargine) in prediabetes (IFG or IGT).
Timeline
- Start
- 2002-02
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin glargine | Protein / enzyme biologic | — | — |